Common Contracts

EX-2.1.5 6 dex215.htm INVESTORS' RIGHTS AGREEMENT PERSEID THERAPEUTICS LLC INVESTORS’ RIGHTS AGREEMENT September 18, 2009 Page -i- (Continued) Page The registrant agrees to furnish to the Securities and Exchange Commission upon request a copy of any...

Investors' Rights Agreement • May 5th, 2020 • Delaware

• Contract Type
  Investors' Rights Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

This Investors’ Rights Agreement (this “Agreement”) is dated as of September 18, 2009, and is between Perseid Therapeutics LLC, a Delaware limited liability company (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”). Astellas Pharma Inc. (“Astellas”), for purposes of Sections 5.1(h) and 5.1(i) only, and Astellas US Holding, Inc. (“Astellas US”), for the purposes of Section 5.1(g) only, shall also be parties herein. All capitalized terms used and not defined herein shall have such meanings as set forth in the Master Joint Venture Agreement by and between Maxygen, Inc. (“Maxygen”), Astellas, and Astellas Bio Inc. (“Bio”) dated as of June 30, 2009 (the “Joint Venture Agreement”).

PERSEID THERAPEUTICS LLC INVESTORS’ RIGHTS AGREEMENT September 18, 2009

Investors’ Rights Agreement • September 21st, 2009 • Maxygen Inc • Services-commercial physical & biological research • Delaware

• Contract Type
  Investors’ Rights Agreement
• Filed
  September 21st, 2009
• Company
  Maxygen Inc
• Industry
  Services-commercial physical & biological research
• Jurisdiction
  Delaware

This Investors’ Rights Agreement (this “Agreement”) is dated as of September 18, 2009, and is between Perseid Therapeutics LLC, a Delaware limited liability company (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”). Astellas Pharma Inc. (“Astellas”), for purposes of Sections 5.1(h) and 5.1(i) only, and Astellas US Holding, Inc. (“Astellas US”), for the purposes of Section 5.1(g) only, shall also be parties herein. All capitalized terms used and not defined herein shall have such meanings as set forth in the Master Joint Venture Agreement by and between Maxygen, Inc. (“Maxygen”), Astellas, and Astellas Bio Inc. (“Bio”) dated as of June 30, 2009 (the “Joint Venture Agreement”).

CPC INVESTORS’ RIGHTS AGREEMENT

Investors’ Rights Agreement • July 1st, 2009 • Maxygen Inc • Services-commercial physical & biological research • Delaware

• Contract Type
  Investors’ Rights Agreement
• Filed
  July 1st, 2009
• Company
  Maxygen Inc
• Industry
  Services-commercial physical & biological research
• Jurisdiction
  Delaware

This Investors’ Rights Agreement (this “Agreement”) is dated as of [ ], 2009, and is between CPC, a Delaware limited liability company (the “Company”), and the persons and entities listed on Exhibit A (each, an “Investor” and collectively, the “Investors”). Astellas Pharma Inc. (“Astellas”), for purposes of Sections 5.1(h) and 5.1(i) only, and Astellas US Holding, Inc. (“Astellas US”), for the purposes of Section 5.1(g) only, shall also be parties herein. All capitalized terms used and not defined herein shall have such meanings as set forth in the Master Joint Venture Agreement by and between Maxygen, Inc. (“Maxygen”), Astellas, and Astellas Bio Inc. (“Bio”) dated as of June 30, 2009 (the “Joint Venture Agreement”).